LexaGene Successfully Completes CRADA with US Army

BEVERLY, Mass., May 03, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular...

Related Keywords

Randy Hofmann ,Jack Regan ,Development Agreement ,Excet Inc ,Technical Group Leader ,Program Executive Office For Chemical ,Lexagene Holdings Inc ,Chemical Biological Center ,Nuclear Defense ,Us Army ,Gene Holdings ,Biological Center ,Cooperative Research ,Joint Program Executive Office ,Joint Project Lead ,Defense Biological Product Assurance Office ,Tsx Venture Exchange Lxg ,